BNP Paribas Asset Management’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
Other funds holding TMDX
NAMI
HRCM
B
BNP Paribas Asset Management's TMDX Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its Transmedics (TMDX) stake by 15% in Q2 2026, selling an estimated $7.28K and leaving 488 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.
BNP Paribas Asset Management first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $57.1K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.
- BNP Paribas Asset Management held 488 shares of Transmedics worth $32.4K as of Q2 2026.
- BNP Paribas Asset Management sold 86 Transmedics shares in Q2 2026, an estimated $7.28K.
- Transmedics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1921 holding.
- BNP Paribas Asset Management first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
- BNP Paribas Asset Management's Transmedics position peaked at $57.1K in Q1 2026.
- 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.